Insights

Acquisition Potential Menarini Stemline's recent acquisition by Menarini Group indicates a strategic partnership with a focus on oncology treatments. This presents an opportunity for cross-selling products and services to the wider Menarini Group's network.

Innovative Therapeutics Stemline Therapeutics' development of novel small molecule inhibitors using AI technology showcases a commitment to innovation in cancer treatment. Positioning your products as complementary to these advancements can open doors for collaborations.

Regulatory Approvals Stemline's successful FDA approval for ELZONRIS demonstrates expertise in navigating regulatory processes. Highlighting your company's compliance and track record with regulatory bodies can strengthen sales pitches in the pharmaceutical sector.

Investment in Assets The significant investment by Stemline in acquiring commercial rights for elacestrant presents an opportunity for synergy. Demonstrating how your solutions can enhance the value of such assets can lead to discussions on partnerships or licensing agreements.

Financial Stability With revenue in the range of $100M - 1B, Menarini Stemline exhibits financial strength. Leveraging this stability can instill confidence in potential clients regarding the sustainability and reliability of engaging in long-term business relationships.

Similar companies to Menarini Stemline

Menarini Stemline Tech Stack

Menarini Stemline uses 8 technology products and services including Sucuri, MySQL, DreamWeaver, and more. Explore Menarini Stemline's tech stack below.

Sucuri
Content Delivery Network
MySQL
Database
DreamWeaver
Editors
Open Graph
Miscellaneous
RSS
Miscellaneous
reCAPTCHA
Security
MediaElement.js
Video Players
Contact Form 7
Web Platform Extensions

Media & News

Menarini Stemline's Email Address Formats

Menarini Stemline uses at least 1 format(s):

Menarini Stemline Email Formats	Example	Percentage
FLast@stemline.com	JDoe@stemline.com	95%
Last@stemline.com	Doe@stemline.com	3%
First@stemline.com	John@stemline.com	1%
FL@stemline.com	JD@stemline.com	1%

Frequently Asked Questions

Where is Menarini Stemline's headquarters located?

Menarini Stemline's main headquarters is located at 750 Lexington Avenue 11th Floor New York, New York 10022 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Menarini Stemline's phone number?

You can contact Menarini Stemline's main corporate office by phone at

+1-646-502-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Menarini Stemline's official website and social media links?

Menarini Stemline's official website is stemline.com and has social profiles on LinkedIn.

How much revenue does Menarini Stemline generate?

As of September 2024, Menarini Stemline's annual revenue reached $750M.

What is Menarini Stemline's SIC code NAICS code?

Menarini Stemline's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Menarini Stemline have currently?

As of September 2024, Menarini Stemline has approximately 558 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer And Co-Founder: T. C.Chief Commercial Officer: A. R.Chief Medical Officer/Global Head Of R&d In Menarini Stemline: N. H.. Explore Menarini Stemline's employee directory with LeadIQ.

What industry does Menarini Stemline belong to?

Menarini Stemline operates in the Biotechnology Research industry.

What technology does Menarini Stemline use?

Menarini Stemline's tech stack includes SucuriMySQLDreamWeaverOpen GraphRSSreCAPTCHAMediaElement.jsContact Form 7.

What is Menarini Stemline's email format?

Menarini Stemline's email format typically follows the pattern of . Find more Menarini Stemline email formats with LeadIQ.

Menarini Stemline

Biotechnology ResearchNew York, United States501-1000 Employees

The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer. 

Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. 

Netiquette & Privacy Notice: https://bit.ly/48X6JSN

Company Overview

Headquarters: 750 Lexington Avenue 11th Floor New York, New York 10022 US
Phone number: ✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-646-502-****
Website: stemline.com
SIC Code: 8731 - Commercial Physical and Biological Research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 501-1000

Media & News

Funding & Financials

$100M$1B
Menarini Stemline's revenue is in the range of $100M$1B

Funding & Financials

$100M$1B
Menarini Stemline's revenue is in the range of $100M$1B

Company Leadership

T. C.
Chief Executive Officer And Co-Founder
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. R.
Chief Commercial Officer
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. H.
Chief Medical Officer/Global Head Of R&d In Menarini Stemline
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. P. C.
Vice President Of Sales - Solid Tumors
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. T.
Vice President Of Clinical Development, Breast Cancer
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

M. C.
Executive Director, Head, U.S. Commercial Distribution And Patient Services
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. B.
Vice President, Global Head Of R&d Cmc
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. G.
Avp, Commercial Excellence
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. A. G.
Senior Vice President Global Clinical Development And Medical Affairs
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. D.
Vice President, Medical Affairs
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Menarini Stemline and Millions of Other Companies
Sign up for full access to Menarini Stemline information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Menarini Stemline

Aileron Therapeutics

Genmab

Roche

Bristol Myers Squibb

Sanofi

Pfizer

AstraZeneca

Novartis

Daiichi Sankyo

Eli Lilly and Company

Menarini Stemline Tech Stack

Media & News

Stemline Therapeutics, Inc. is developing novel, small molecule KAT6A inhibitor.

Stemline Therapeutics, Inc. invested into assets: commercial rights for elacestrant in the amount of $30M on Jan 1st '20.

Stemline Therapeutics, Inc. has issues with violated the federal securities laws.

Stemline Therapeutics, Inc. launched ELZONRIS for the treatment of blastic plasmacytoid dendritic cell neoplasm on Dec 1st '18.

Menarini Group acquires Stemline Therapeutics, Inc. for $0.

Stemline Therapeutics, Inc. had issues with possible breaches of fiduciary duties and other violations of law on May 4th '20.

MENARINI Group partnered with Stemline Therapeutics, Inc. on Nov 4th '18.

Menarini Stemline's Email Address Formats

Frequently Asked Questions

Where is Menarini Stemline's headquarters located?

What is Menarini Stemline's phone number?

What is Menarini Stemline's official website and social media links?

How much revenue does Menarini Stemline generate?

What is Menarini Stemline's SIC code NAICS code?

How many employees does Menarini Stemline have currently?

What industry does Menarini Stemline belong to?

What technology does Menarini Stemline use?

What is Menarini Stemline's email format?

Menarini Stemline

Company Overview

Media & News

Stemline Therapeutics, Inc. is developing novel, small molecule KAT6A inhibitor.

Stemline Therapeutics, Inc. invested into assets: commercial rights for elacestrant in the amount of $30M on Jan 1st '20.

Stemline Therapeutics, Inc. has issues with violated the federal securities laws.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?